PIK3CA and cancer: It is safe to assume that inactivation of this pathway in luminal B cancers may account for their more aggressive phenotype compared to luminal A. The vast majority of basal-like cancers (80%) carried TP53 mutations; only 9% of them had PIK3CA mutations, while the rest of the luminal SMGs were absent or near absent.